Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

Molecular Factors Affecting Cell Division

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Protocol to evaluate markers of reactiveoxygen species and labile iron from a single sample across in vitro and in in vivo lung cancer models.

STAR protocols·2026

Same author

NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

Molecular cancer therapeutics·2026

Same author

Sodium Channel Isoform Diversity Underlies Chamber-Specific Cardiac Excitability.

Circulation research·2026

Same author

Short SCN5A Transcript Yields a NaV1.5 Fragment Influencing Cardiac Metabolism.

Circulation research·2026

Same author

FLASH: New intersection of physics, chemistry, biology, and cancer medicine.

Reviews of modern physics·2026

Same author

P7C3-A20 prevents whole brain radiotherapy-induced chronic hippocampal redox imbalance and neuropsychiatric impairment in mice.

Redox biology·2026

Search research articles

Related Experiment Video

Updated: May 22, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Mitoregulin Promotes Cell Cycle Progression in Non-Small Cell Lung Cancer Cells.

Colleen S Stein¹, Connor R Linzer¹, Collin D Heer²

¹Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

International Journal of Molecular Sciences

|March 13, 2025

Summary

Mitoregulin (MTLN) promotes cancer cell growth by regulating mitochondrial energetics and cell cycle progression. Silencing MTLN in non-small cell lung cancer (NSCLC) inhibits proliferation and reduces reactive oxygen species, suggesting it as a potential therapeutic target.

Keywords:

LINC00116 cancer therapy cell cycle arrest long non-coding RNA miR-17 micropeptide mitochondria oxidant oxidative stress prooxidant

More Related Videos

The Soft Agar Colony Formation Assay

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Experiment Videos

Last Updated: May 22, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

The Soft Agar Colony Formation Assay

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Area of Science:

Mitochondrial biology
Cancer research
Cell cycle regulation

Background:

Mitoregulin (MTLN) is a mitochondrial microprotein influencing cellular energy.
MTLN expression is elevated in many cancers and linked to prognosis in non-small cell lung cancer (NSCLC).
Lower MTLN levels correlate with better survival in lung adenocarcinoma (LUAD).

Purpose of the Study:

To investigate the role of MTLN in NSCLC cell proliferation and response to oxidative stress.
To explore MTLN silencing as a potential therapeutic strategy for NSCLC.

Main Methods:

MTLN gene silencing in A549 NSCLC cells.
Cell cycle analysis (G1 phase proportion).
Western blotting for cell cycle regulatory proteins (ERK, MYC, CDK2, RB, p27Kip1, cyclin D1).
Clonogenic survival assays.
Redox sensing using roGFP2-Orp1 to measure H2O2 levels.
Combination drug treatments (BSO + auranofin) to induce ROS.

Main Results:

MTLN silencing reduced NSCLC cell proliferation, increased G1 phase arrest, and altered cell cycle protein levels.
MTLN knockdown decreased cytosolic and mitochondrial H2O2 levels.
MTLN-silenced cells exhibited reduced clonogenic survival and partial resistance to ROS-inducing drugs.
A contradictory increase in cyclin D1 was observed despite G1 arrest.

Conclusions:

MTLN promotes G1/S cell cycle transition via H2O2 signaling.
MTLN silencing inhibits NSCLC growth and confers partial resistance to oxidative stress.
Targeting MTLN represents a potential therapeutic avenue for NSCLC.